What is the role of clinical trials for the treatment of tuberculosis and what are the alternatives?

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 4, 2010, Pages 380-381

  Nunn, Andrew ^a  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; RIFAPENTINE; STREPTOMYCIN; THIOACETAZONE;

CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG EFFICACY; EDITORIAL; GOLD STANDARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; LUNG TUBERCULOSIS; MIXED INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SHORT COURSE THERAPY; TREATMENT DURATION; TREATMENT OUTCOME;

ANTITUBERCULAR AGENTS; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 77950321752     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (10)

1. Medical Research Council (1948). Streptomycin treatment of pulmonary tuberculosis. BMJ 1948; ii: 769-782.
2. Pocock S J. Clinical trials: a practical approach. London, UK: Wiley Medical Publications, 1983.
3. Fox W, Ellard G A, Mitchison D A. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis 1999; 3 (Suppl): S231-S279.
4. Cochrane A L. 1931-1971: a critical review, with particular reference to the medical profession. In: Teeling-Smith G, Wells N, eds. Medicines for the year 2000. London, UK: Office of Health Economics, 1979, pp 1-11.
5. Jindani A, Nunn A J, Enarson D A. Two eight-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. Lancet 2004, 364: 1244-1251.
6. Kent P W, Fox W, Miller A B, Nunn A J, Tall R, Mitchison D A. The therapy of pulmonary tuberculosis in Kenya: a comparison of the results achieved in controlled clinical trials with those achieved by the routine treatment services. Tubercle 1970; 51: 24-38.
7. Algerian Working Group/British Medical Research Council. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Am Rev Respir Dis 1984; 129: 921-928.
8. Second East African/British Medical Research Council Kenya Tuberculosis Survey Follow-up. Tuberculosis in Kenya: followup of the second (1974) national sampling survey and a comparison with the follow-up data from the first (1964) national sampling survey. Tubercle 1979; 60: 125-149.
9. Tanzania/British Medical Research Council Collaborative Study. Tuberculosis in Tanzania-a national survey of newly notified cases. Tubercle 1985; 66: 161-178.
10. Tam C M, Chan S L, Lam C W, et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis. Initial report. Am J Respir Crit Care Med 1998; 157(6 Pt 1): 1726-1733.